12
OBAT HIPERTENSI dr. Hj. Darmiana, MM

OBAT HIPERTENSI

Embed Size (px)

DESCRIPTION

a

Citation preview

OBAT HIPERTENSIdr. Hj. Darmiana, MM

Mencegah komplikasi Menurunkan kejadian vaskuler

Kardiovaskuler Serebrovaskuler Renovaskuler

Melalui penurunan dan pengendalian tekanan darah sesuai target serta pengobatan faktor-faktor risiko yang reversibel

TUJUAN PENGOBATAN

Management of hypertension

1. Non pharmacological

2. Pharmacological

MODIFIKASI GAYA HIDUP UNTUK PENGENDALIAN

HIPERTENSIMODIFI-KASI

REKOMEN-DASI

PENURUN-AN TDS

BB BMI 18,5-24,5 5-20mmHg , setiap turun BB10kg

DASH Konsumsi buah, sayur banyak, susu rendah lemak&lemak jenuh

8-14mmHg

Asupan garam

≤ 2,4gr/hari 2-8mmHg

Aktifitas fisik OR teratur 30meit perhari

4-9gr

Alkohol Batasi 2-4gr

Pharmacological

0BAT INDIVIDUAL SEUMUR HIDUP PRINSIP KENDALIKAN TEKANAN DARAH CEGAH KOMPLIKASI

Stratification of CV risk in four categories

Blood pressure (mmHg)

Other risk factors, TOD or disease

Normal SBP 120-129 or DBP 80-84

High normal SBP 130-139 or DBP 85-89

Grade 1 HTSBP 140-159 or DBP 90-99

Grade 2 HTSBP 160-179 or DBP 100-109

Grade 3 HT SBP ≥180 or DBP ≥110

No other risk factors

Average risk

Average risk

Low added risk

Moderate added risk

High added risk

1-2 risk factorsLow added risk

Low added risk

Moderate added risk

Moderate added risk

Very high added risk

3 or more risk factors, TOD, DM or MS

Moderate added risk

High added risk

High added risk

High added risk

Very high added risk

Established CV or renal disease

Very high added risk

Very high added risk

Very high added risk

Very high added risk

Very high added risk

Guidelines Committee of the 2003 ESH-ESC guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53

FAKTOR RESIKO KARDIOVASKULER

Ada tidaknya Faktor Resiko Usia lanjut Male gender Merokok Riwayat keluarga prematur cardiovaskuler

disease ( laki-laki < 55 tahun dan perempuan < 65 tahun)

Gangguan lemak (kolesterol atau trigliseride tinggi)

Pola hidup tidak sehat Obesitas Gangguan metabolisme glukosa

Ada tidaknya Target Organ yang rusak Ginjal : laboratorium Jantung : rekam jantung (EKG) Mata : funduscopy Otak : stroke

Ada tidaknya Aterosklerotic Vasculer Disease

TIA / stroke Penyakit jantung koroner Penyakit arteri perifer

Initiation of antihypertensive treatmentOther risk factors, Target Organ Damage or disease

Normal SBP 120-129 or DBP 80-84

High normal SBP 130-139 or DBP 85-89

Grade 1 HTSBP 140-159 or DBP 90-99

Grade 2 HTSBP 160-179 or DBP 100-109

Grade 3 HT SBP ≥180 or DBP ≥110

No other risk factors

No BP intervention No BP intervention

Lifestyle changes for several months then drug treatment if BP uncontrolled

Lifestyle changes for several weeks then drug treatment if BP uncontrolled

Lifestyle changes + immediate drug treatment

1-2 risk factors

Lifestyle changes Lifestyle changes

Lifestyle changes for several weeks then drug treatment if BP uncontrolled

Lifestyle changes for several weeks then drug treatment if BP uncontrolled

Lifestyle changes + immediate drug treatment

>3 risk factors, MS or TOD Lifestyle changes

Lifestyle changes and consider drug treatment Lifestyle changes +

drug treatmentLifestyle changes + drug treatment

Lifestyle changes + immediate drug treatment

Diabetes Lifestyle changesLifestyle changes + drug treatment

Established CV or renal disease

Lifestyle changes + immediate drug treatment

Lifestyle changes + immediate drug treatment

Lifestyle changes + immediate drug treatment

Lifestyle changes + immediate drug treatment

Lifestyle changes + immediate drug treatment

Uncomplicated hypertension

High CAD risk, Stable Angina, STEMI,

UA/NSTEMI

< 140/90 mmHg

< 130/80 mmHg

Diabetes Mellitus (DM) and/orChronic Kidney Disease

< 130/80 mmHg

Renal Failure with Proteinuria > 1 gr/24 hours

< 125/75 mmHg

Goals of Therapy

LVD < 120/80 mmHg

JNC-7, 2003WHO-ISH/ESH-ESC, 2007

Mosher M, et al. J Clin Hypertens 2008;10(2):390-397

1-blockers

2007 ESH/ESC Guidelines

CCBs

Diuretics

ACE inhibitors

AT1-receptor blockersß-blockers

Mancia G, et al. 2007 ESH/ESC Guidelines for the Management of Arterial Hypertension. J Hypertens 2007;25:1105-1187

TERIMA KASIH